Profile
Mr. Louis J.
Arcudi is a Chief Financial Officer at Sensorion SA and a Co-President & Secretary at Millendo Therapeutics US, Inc. Mr. Arcudi was previously employed as a President, Chief Executive Officer & Director by Millendo Therapeutics, Inc., a CFO, Treasurer & Chief Accounting Officer by Idera Pharmaceuticals, Inc., a Treasurer, VP-Administration & Finance by Peptimmune, Inc., a Senior Director-Finance Business Planning by Genzyme Corp., a Senior Director-Finance & Administration by Genzyme Molecular Oncology, a Chief Financial Officer by Amolyt Pharma SAS, and a Controller by Cognex Corp.
He received his undergraduate degree from Southern New Hampshire University and an MBA from Bryant University.
Louis Arcudi active positions
| Companies | Position | Start |
|---|---|---|
| SENSORION | Director of Finance/CFO | 07/10/2026 |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | President | - |
Former positions of Louis Arcudi
| Companies | Position | End |
|---|---|---|
| MILLENDO THERAPEUTICS | Chief Executive Officer | 25/06/2021 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Director of Finance/CFO | 31/10/2018 |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Director of Finance/CFO | 01/12/2007 |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Director of Finance/CFO | 01/01/2003 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Director of Finance/CFO | 01/01/2003 |
Training of Louis Arcudi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Cognex Corp.
Cognex Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and markets machine vision computer systems | Electronic Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Millendo Therapeutics US, Inc.
Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company which develops a novel treatment for adrenal cancer | Health Technology |
Peptimmune, Inc.
Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Southern New Hampshire University
Southern New Hampshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics and diagnostics | Health Technology |
Bryant University
Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sensorion SA
Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Amolyt Pharma SAS
Amolyt Pharma SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in physical & natural sciences | Commercial Services |
Millendo Therapeutics, Inc.
Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Louis Arcudi
















